Recent literature has demonstrated that, in addition to inducing the remission of diabetes in rodent models, FGF1 induces robust activation of c-Fos and pERK1/2 in the ARH and median eminence (ME), however, the neuronal phenotypes and extent of neuronal activation in the ARH are less clear (5, 7). This evidence concerns the gene FGF1 and diabetes mellitus.